AEON Biopharma, Inc.
AEON
$0.24
$0.001.19%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 90.21% | 68.24% | -718.36% | 31.68% | -173.03% |
| Total Depreciation and Amortization | 5.26% | -5.00% | 5.26% | -5.00% | 5.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -139.40% | -76.67% | 1,245.04% | -37.63% | 135.62% |
| Change in Net Operating Assets | -60.83% | 220.00% | -93.66% | -205.77% | 109.24% |
| Cash from Operations | -40.29% | 44.06% | -81.51% | -24.15% | 73.56% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -46.79% | -- | -100.00% | 0.00% | -99.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 134.95% | -- | -- | -- |
| Cash from Financing | -84.91% | 227.92% | 2,032.14% | 0.00% | -99.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.87% | 210.82% | -16.28% | -25.16% | -119.24% |